Tag: STORM-PE
CX 2026: Venous and lymphatic session highlights continued innovation following recent PE trials
“Are we at the end of the road with this technology?” asked attendees of yesterday’s opening venous and lymphatic session at the 2026 Charing...
New STORM-PE data show improved functional outcomes with CAVT plus anticoagulation
The 90-day results of the STORM-PE randomised controlled trial (RCT) have demonstrated that patients with acute intermediate-high risk pulmonary embolism (PE) who were treated...
Vascular News 109 – January 2026 (US)
In this issue:
CREST-2 analysis: Experts focus on medical management, trial design and plaque imaging following the presentation of landmark trial data
Opinion: Vascular Society...
Vascular News 109 – January 2026 (OUS)
In this issue:
CREST-2 analysis: Experts focus on medical management, trial design and plaque imaging following the presentation of landmark trial data
Opinion: Vascular...
CAVT with anticoagulation significantly improves functional outcomes in PE patients, RCT...
Mechanical thrombectomy by means of computer-assisted vacuum thrombectomy (CAVT) using the 16Fr Lightning Flash system (Penumbra) along with anticoagulation for acute-to-intermediate pulmonary embolism (PE)...
Penumbra’s STORM-PE randomised trial completes enrolment
Penumbra has announced the completion of enrolment in the STORM-PE clinical trial.
The pivotal, prospective, multicentre randomised controlled trial enrolled 100 patients to evaluate computer...
